The irony of proposed changes that will effectively eliminate Special Pricing Arrangements is that they will probably leave government with the choice of paying higher prices or denying patient access. …
Latest Video
New Stories
-
Imugene acquires rights to new oncolytic virus technology
July 16, 2019 - - Latest News -
Focus on reality rather than the language
July 16, 2019 - - Latest News -
Patients hope new inquiry will target PHARMAC
July 16, 2019 - - Latest News -
MA considering whether to drop ACCC authorisation
July 16, 2019 - - Latest News -
Is this farewell to 'preserving prescriber choice'?
July 15, 2019 - - Latest News -
Supply chain payment reform triggered debate over an even more complex issue
July 15, 2019 - - Latest News -
The uniQure experience highlights the commercial challenge
July 15, 2019 - - Latest News